AI assistant
PROCTER & GAMBLE Co — Director's Dealing 2025
Apr 30, 2025
29757_dirs_2025-04-30_66bdc84f-1fb2-47da-9cea-97ce980fc7a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROCTER & GAMBLE Co (PG)
CIK: 0000080424
Period of Report: 2025-04-29
Reporting Person: Davis Jennifer L. (CEO - Health Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-29 | Common Stock | S | 1000 | $161.384 | Disposed | 51964.9178 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | Restricted Stock Units | $ | A | 22.1597 | Acquired | Common Stock (22.1597) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14838.4112 | Indirect |
Footnotes
F1: Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request.
F2: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F3: Reflects adjustment to PST through March 31, 2025.
F4: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F5: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.